Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: A propensity score analysis

Critical Care

Volumn 16, Issue 6, 2012, Pages

  Jung, Boris ^a   Clavieras, Noemie ^a   Nougaret, Stephanie ^b   Molinari, Nicolas ^c   Roquilly, Antoine ^d   Cisse, Moussa ^a   Carr, Julie ^a   Chanques, Gerald ^a   Asehnoune, Karim ^d   Jaber, Samir ^a  

^a UNIVERSITY OF MONTPELLIER   (France)

^b HÔPITAL SAINT ELOI   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETOMIDATE; HYDROCORTISONE; HYPNOTIC SEDATIVE AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PATIENT SAFETY; PRIORITY JOURNAL; SEPTIC SHOCK; TREATMENT OUTCOME; ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; INTENSIVE CARE UNIT; LENGTH OF STAY; MIDDLE AGED; PROCEDURES; PROPENSITY SCORE; SHOCK, SEPTIC; STATISTICS AND NUMERICAL DATA;

AGED; ETOMIDATE; FEMALE; HUMANS; HYDROCORTISONE; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; LENGTH OF STAY; MALE; MIDDLE AGED; PROPENSITY SCORE; SHOCK, SEPTIC;

EID: 84869236472     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11871     Document Type: Article

References (42)

1. Baillard C, Fosse JP, Sebbane M, Chanques G, Vincent F, Courouble P, Cohen Y, Eledjam JJ, Adnet F, Jaber S. Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med 2006, 174:171-177. 10.1164/rccm.200509-1507OC, 16627862.
2. Jaber S, Amraoui J, Lefrant JY, Arich C, Cohendy R, Landreau L, Calvet Y, Capdevila X, Mahamat A, Eledjam JJ. Clinical practice and risk factors for immediate complications of endotracheal intubation in the intensive care unit: a prospective, multiple-center study. Crit Care Med 2006, 34:2355-2361. 10.1097/01.CCM.0000233879.58720.87, 16850003.
3. Petrini F, Accorsi A, Adrario E, Agro F, Amicucci G, Antonelli M, Azzeri F, Baroncini S, Bettelli G, Cafaggi C, Cattano D, Chinelli E, Corbanese U, Corso R, Della Puppa A, Di Filippo A, Facco E, Favaro R, Favero R, Frova G, Giunta F, Giurati G, Giusti F, Guarino A, Iannuzzi E, Ivani G, Mazzon D, Menarini M, Merli G, Mondello E, et al. Recommendations for airway control and difficult airway management. Minerva Anestesiol 2005, 71:617-657.
4. Griesdale DE, Bosma TL, Kurth T, Isac G, Chittock DR. Complications of endotracheal intubation in the critically ill. Intensive Care Med 2008, 34:1835-1842. 10.1007/s00134-008-1205-6, 18604519.
5. Jaber S, Jung B, Corne P, Sebbane M, Muller L, Chanques G, Verzilli D, Jonquet O, Eledjam JJ, Lefrant JY. An intervention to decrease complications related to endotracheal intubation in the intensive care unit: a prospective, multiple-center study. Intensive Care Med 2010, 36:248-255. 10.1007/s00134-009-1717-8, 19921148.
6. Jabre P, Combes X, Lapostolle F, Dhaouadi M, Ricard-Hibon A, Vivien B, Bertrand L, Beltramini A, Gamand P, Albizzati S, Perdrizet D, Lebail G, Chollet-Xernard C, Maxime V, Brun-Buisson C, Lefrant JY, Bollaert PE, Megarbane B, Ricard JD, Anguel N, Vicaut E, Adnet F. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 2009, 374:293-300. 10.1016/S0140-6736(09)60949-1, 19573904.
7. Walz JM, Zayaruzny M, Heard SO. Airway management in critical illness. Chest 2007, 131:608-620. 10.1378/chest.06-2120, 17296669.
8. Malerba G, Romano-Girard F, Cravoisy A, Dousset B, Nace L, Levy B, Bollaert PE. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med 2005, 31:388-392. 10.1007/s00134-004-2550-8, 15703896.
9. Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984, 310:1415-1421. 10.1056/NEJM198405313102202, 6325910.
10. Payen JF, Dupuis C, Trouve-Buisson T, Vinclair M, Broux C, Bouzat P, Genty C, Monneret D, Faure P, Chabre O, Bosson JL. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial. Crit Care Med 2012, 40:29-35. 10.1097/CCM.0b013e31822d7938, 21926601.
11. den Brinker M, Hokken-Koelega AC, Hazelzet JA, de Jong FH, Hop WC, Joosten KF. One single dose of etomidate negatively influences adrenocortical performance for at least 24 h in children with meningococcal sepsis. Intensive Care Med 2008, 34:163-168. 10.1007/s00134-007-0836-3, 2668631, 17710382.
12. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008, 36:1937-1949. 10.1097/CCM.0b013e31817603ba, 18496365.
13. Annane D, Bellissant E. Prognostic value of cortisol response in septic shock. JAMA 2000, 284:308-309. 10.1001/jama.284.3.308, 10891961.
14. de Jong MF, Beishuizen A, Spijkstra JJ, Groeneveld AB. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock. Crit Care Med 2007, 35:1896-1903. 10.1097/01.CCM.0000275387.51629.ED, 17568326.
15. Jung B, Nougaret S, Chanques G, Mercier G, Cisse M, Aufort S, Gallix B, Annane D, Jaber S. Absence of adrenal gland enlargement during septic shock predicts mortality: a computed tomography scan study of 239 patients. Anesthesiology 2011, 115:334-343. 10.1097/ALN.0b013e318225cfd7, 21720239.
16. Annane D. ICU physicians should abandon the use of etomidate!. Intensive Care Med 2005, 31:325-326. 10.1007/s00134-005-2560-1, 15750800.
17. de Jong MF, Beishuizen A, Spijkstra JJ, Girbes AR, Groeneveld AB. Relative adrenal insufficiency: an identifiable entity in nonseptic critically ill patients?. Clin Endocrinol (Oxf) 2007, 66:732-739.
18. Jackson WL. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal. Chest 2005, 127:1031-1038. 10.1378/chest.127.3.1031, 15764790.
19. Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med 2011, 37:901-910. 10.1007/s00134-011-2160-1, 21373823.
20. Cuthbertson BH, Sprung CL, Annane D, Chevret S, Garfield M, Goodman S, Laterre PF, Vincent JL, Freivogel K, Reinhart K, Singer M, Payen D, Weiss YG. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009, 35:1868-1876. 10.1007/s00134-009-1603-4, 19652948.
21. Lipiner-Friedman D, Sprung CL, Laterre PF, Weiss Y, Goodman SV, Vogeser M, Briegel J, Keh D, Singer M, Moreno R, Bellissant E, Annane D. Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med 2007, 35:1012-1018. 10.1097/01.CCM.0000259465.92018.6E, 17334243.
22. Mohammad Z, Afessa B, Finkielman JD. The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care 2006, 10:R105. 10.1186/cc4979, 1751010, 16859529.
23. Dmello D, Taylor S, O'Brien J, Matuschak GM. Outcomes of etomidate in severe sepsis and septic shock. Chest 2010, 138:1327-1332. 10.1378/chest.10-0790, 20651024.
24. Ray DC, McKeown DW. Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care 2007, 11:R56. 10.1186/cc5916, 2206408, 17506873.
25. Riche FC, Boutron CM, Valleur P, Berton C, Laisne MJ, Launay JM, Chappuis P, Peynet J, Vicaut E, Payen D, Cholley BP. Adrenal response in patients with septic shock of abdominal origin: relationship to survival. Intensive Care Med 2007, 33:1761-1766. 10.1007/s00134-007-0770-4, 17618417.
26. Nougaret S, Jung B, Aufort S, Chanques G, Jaber S, Gallix B. Adrenal gland volume measurement in septic shock and control patients: a pilot study. Eur Radiol 2010, 20:2348-2357. 10.1007/s00330-010-1804-9, 20521055.
27. Annane D. Corticosteroids for severe sepsis: an evidence-based guide for physicians. Annals Intensive Care 2011, 1:1-7.
28. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124. 10.1056/NEJMoa071366, 18184957.
29. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008, 61:344-349. 10.1016/j.jclinepi.2007.11.008, 18313558.
30. Vinclair M, Broux C, Faure P, Brun J, Genty C, Jacquot C, Chabre O, Payen JF. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med 2008, 34:714-719. 10.1007/s00134-007-0970-y, 18092151.
31. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Servansky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437.
32. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
33. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews in emergency medicine research: where are the methods?. Ann Emerg Med 1996, 27:305-308. 10.1016/S0196-0644(96)70264-0, 8599488.
34. Gayat E, Pirracchio R, Resche-Rigon M, Mebazaa A, Mary JY, Porcher R. Propensity scores in intensive care and anaesthesiology literature: a systematic review. Intensive Care Med 2011, 36:1993-2003.
35. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
36. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26:1793-1800. 10.1097/00003246-199811000-00016, 9824069.
37. Fernandez R, Tizon AI, Gonzalez J, Monedero P, Garcia-Sanchez M, de-la-Torre MV, Ibanez P, Frutos F, del-Nogal F, Gomez MJ, Marcos A, Hernandez G. Intensive care unit discharge to the ward with a tracheostomy cannula as a risk factor for mortality: a prospective, multicenter propensity analysis. Crit Care Med 2011, 39:2240-2245. 10.1097/CCM.0b013e3182227533, 21670665.
38. Suarez D, Haro JM, Novick D, Ochoa S. Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studies. J Clin Epidemiol 2008, 61:525-530. 10.1016/j.jclinepi.2007.11.007, 18471655.
39. de Jong FH, Mallios C, Jansen C, Scheck PA, Lamberts SW. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J Clin Endocrinol Metab 1984, 59:1143-1147. 10.1210/jcem-59-6-1143, 6092411.
40. Hildreth AN, Mejia VA, Maxwell RA, Smith PW, Dart BW, Barker DE. Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. J Trauma 2008, 65:573-579. 10.1097/TA.0b013e31818255e8, 18784570.
41. Chang HC, Lin KH, Tai YT, Chen JT, Chen RM. Lipoteichoic acid-induced TNF-alpha and IL-6 gene expressions and oxidative stress production in macrophages are suppressed by ketamine through downregulating Toll-like receptor 2-mediated activation oF ERK1/2 and NFκB. Shock 2010, 33:485-492.
42. Yu M, Shao D, Liu J, Zhu J, Zhang Z, Xu J. Effects of ketamine on levels of cytokines, NF-κB and TLRs in rat intestine during CLP-induced sepsis. Int Immunopharmacol 2007, 7:1076-1082. 10.1016/j.intimp.2007.04.003, 17570324.